| JXSB2000025 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-09-30 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-09-29 | view |
| JYSB2100036 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-01-28 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-27 | view |
| JXSL2000223 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-14 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-12-10 | view |
| JXSL2000152 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-09-14 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-09-11 | view |
| JXSL1900012 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2019-02-18 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2019-02-15 | view |
| JYSB1800027 | Pembrolizumab注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2018-02-11 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2018-04-10 | view |
| JXSB2000037 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-11-23 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-11-21 | view |
| JXSL2000034 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2020-04-13 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-04-11 | view |
| JXSL1800030 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2018-09-12 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2018-10-29 | view |
| JYSB2000288 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-06-28 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-06-25 | view |
| JXSB2100028 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-03-24 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-23 | view |
| JXSL1900017 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2019-02-20 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2019-02-19 | view |
| JXSS2000063 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-12-14 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-12-11 | view |
| JXSL1900089 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2019-09-13 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2019-09-12 | view |
| JXSL2000005 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2020-01-22 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-01-21 | view |
| JYSB1700202 | Pembrolizumab注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2017-11-23 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2018-01-17 | view |
| JXSL1900122 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2019-11-22 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2019-11-21 | view |
| JXSL2000015 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2020-02-03 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-01-23 | view |
| JXSB2100007 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-08 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-19 | view |
| JXSL2000194 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-02 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-10-30 | view |
